Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Tout cancer hématologique
- | Specialty :
- Thérapies Ciblées
Extract
A phase I study to evaluate the safety and tolerability of the histone deacetylase inhibitor, CHR-2845, in patients with advanced or treatment refractory haematological diseases or lymphoid malignancies
Scientific Abstract
en cours d'intégration;